THE CYTO-TOXIC ACTIVITY OF CISPLATIN, CARBOPLATIN AND TENIPOSIDE ALONE AND COMBINED DETERMINED ON 4 HUMAN SMALL CELL LUNG-CANCER CELL-LINES BY THE CLONOGENIC-ASSAY

被引：26

作者：

ROED, H

VINDELOV, LL

CHRISTENSEN, IJ

SPANGTHOMSEN, M

HANSEN, HH

机构：

[1] FINSEN INST,DEPT ONCOL B,DK-2100 COPENHAGEN O,DENMARK

[2] FINSEN INST,DEPT INTERNAL MED,DK-2100 COPENHAGEN O,DENMARK

[3] FINSEN INST,FINSEN LAB,DK-2100 COPENHAGEN O,DENMARK

[4] UNIV COPENHAGEN,INST PATHOL ANAT,DK-1168 COPENHAGEN K,DENMARK

来源：

EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY | 1988年 / 24卷 / 02期

关键词：

D O I：

10.1016/0277-5379(88)90261-1

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：247 / 253

页数：7

共 22 条

[1]

Alberts DS, 1980, CLONING HUMAN TUMOR, P351

[2] STUDIES OF CROSS-RESISTANCE, SYNERGISTIC COMBINATIONS AND BLOCKING OF ACTIVITY OF PLATINUM DERIVATIVES [J].

BURCHENAL, JH ;

KALAHER, K ;

DEW, K ;

LOKYS, L ;

GALE, G .

BIOCHIMIE, 1978, 60 (09) :961-965

[3] EARLY CLINICAL-STUDIES WITH CIS-DIAMMINE-1,1-CYCLOBUTANE DICARBOXYLATE PLATINUM-II [J].

CALVERT, AH ;

HARLAND, SJ ;

NEWELL, DR ;

SIDDIK, ZH ;

JONES, AC ;

MCELWAIN, TJ ;

RAJU, S ;

WILTSHAW, E ;

SMITH, IE ;

BAKER, JM ;

PECKHAM, MJ ;

HARRAP, KR .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1982, 9 (03) :140-147

[4]

CURT GA, 1983, CANCER RES, V43, P4470

[5]

DREWINKO B, 1976, CANCER TREAT REP, V60, P1619

[6]

EVANS WK, 1984, CANCER, V53, P1461, DOI 10.1002/1097-0142(19840401)53:7<1461::AID-CNCR2820530706>3.0.CO

[7]

2-N

[8]

GUPTA RS, 1983, CANCER RES, V43, P1568

[9] CLINICAL KINETICS OF INTACT CISPLATIN AND SOME RELATED SPECIES [J].

HIMMELSTEIN, KJ ;

PATTON, TF ;

BELT, RJ ;

TAYLOR, S ;

REPTA, AJ ;

STERNSON, LA .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 29 (05) :658-664

[10]

MICETICH KC, 1985, P AM ASS CANCER RES, V26, P1037

← 1 2 3 →